Scientists at the
Gladstone Institutes have discovered that environmental factors critically
influence the growth of a type of stem cell--called an iPS cell--that is
derived from adult skin cells. This discovery offers newfound understanding of
how these cells form, while also advancing science closer to stem cell-based
therapies to combat disease.
Researchers in the laboratory of Gladstone Senior
Investigator Shinya Yamanaka, MD, PhD, have for the first time shown that
protein factors released by other cells affect the "reprogramming"
of adult cells into stem cells known as
induced pluripotent
stem cells, or iPS cells. The scientists—who collaborated on this research
with colleagues from the University of California, San Francisco
(UCSF)—announce their findings today online inCell Stem Cell.
In 2007, Dr. Yamanaka discovered a recipe of specific
proteins to add to human skin cells as a way to induce them into becoming iPS
cells—which act very much like embryonic stem cells. Many see iPS cell
technology as a new platform for drug discovery and the study of disease
fundamentals—while avoiding the ethical issues surrounding research involving
embryonic stem cells. But questions remain about the most efficient way to
cultivate iPS cells.
"We've reinforced our hypothesis that the cell's
environment is vital to the reprogramming process," said Dr. Yamanaka, who
did his postdoctoral studies at Gladstone in the 1990s, returning here in 2007
as a senior investigator. "We can now expand our understanding of cell
development—and use iPS cells to model conditions such as Alzheimer's and heart
disease."
Normally when researchers convert skin cells into iPS cells, the
cells rest on a special layer of materials in a petri dish. The layer includes
"feeder" cells that provide nutrients required for the iPS cells to
grow and reproduce. In this study, performed at the Roddenberry Center for Stem
Cell Biology & Medicine at Gladstone, scientists generated human iPS cell
lines by using a method in which the feeder layer secretes a protein called
LIF. Dr. Yamanaka, who invented this so-called "Kyoto" method, also
directs the Center for iPS Cell Research and Application at Kyoto University
and is a professor at UCSF, with which Gladstone is affiliated. UCSF
collaborators on this research include co-senior author Barbara Panning, PhD,
and Karen Leung, PhD.
The researchers then analyzed LIF's importance in the
growth of female iPS cells. Female iPS cells contain two copies of the
X-chromosome, which is one of two sex chromosomes. While males carry one X and
one Y-chromosome, females' two X-chromosomes could result in a potentially
toxic double dose of genes—except for a unique evolutionary mechanism whereby
one of the two X's is silenced in a process known as
"X-inactivation." This process, which occurs early during the
development of the embryo, ensures that females, like males, have one
functional copy of the X-chromosome in each cell. But exactly how
X-inactivation happens is unknown.
To research this, Gladstone scientists generated female
iPS cells on feeder layers without LIF and found that one of the X-chromosomes
in each iPS cell remained silent. Those iPS cells that grew on a layer of cells
with the LIF protein, however, grew with two activated X-chromosomes. Then, by
taking a cell from a non-LIF cell layer and transferring it to a LIF-cell
layer, the iPS cell's inactive X-chromosome switched on and became even more
like embryonic stem cells. These results are crucial for future studies of how
iPS cells grow and mature. And because this iPS technology lets scientists
create stem cells from patients with a specific disease, this new finding could
lead to a far-superior human model for studying disease and testing new drugs.
"These results will make it possible to readily
generate stable, double-active, higher-quality X-chromosome iPS cells, and study the process more
closely," said Gladstone Research Scientist Kiichiro Tomoda, PhD, who is
the paper's lead author "Our findings also reinforce work from other
Gladstone scientists showing that the cell environment is critical to the
reprogramming process."
Provided by Gladstone Institutes
No comments:
Post a Comment